Literature DB >> 18319530

Life time risk for development of ten major cancers in India and its trends over the years 1982 to 2000.

L Satyanarayana1, Smita Asthana.   

Abstract

BACKGROUND: Understanding cancer magnitude, risk and trends will be of help in cancer control programs. AIM: To study trends in cumulative risk up to 64 years of age as lifetime risk of developing major cancers in India during the years 1982 to 2000.
DESIGN: Retrospective.
SETTING: Secondary sources of cancer-registration data.
MATERIALS AND METHODS: Data on age-specific cancer-incidence rates were collected for patients 0-64 years of age of either sex for 10 major cancer sites from the National Cancer Registry Program (NCRP) reports of India from Mumbai, Chennai, Bangalore, Bhopal and Delhi; and Barshi registries for the years 1982 or 1988 to 2000. STATISTICAL ANALYSIS: Cumulative risks computed for lifetime development of cancer. Linear trends were studied using simple linear regressions.
RESULTS: The lifetime risk among females for the 10 cancer sites ranged from 0.02 to 3.3% and from 0.04 to 2.4% for the years 1982 and 2000 respectively; whereas among males, it ranged from 0.04 to 0.89% and from 0.05 to 0.95% respectively. Significant (P<0.05) increasing trends were observed for breast, non-Hodgkin's lymphoma (NHL), gallbladder, thyroid and ovary cancers among females; while declining trends were observed for cervix, mouth, stomach, esophagus and tongue cancers. Among males, significant (P<0.05) increasing trends wre observed for NHL and prostate cancer; whereas declining trends were observed for stomach, liver, hypopharynx and tongue cancers. Cancers of mouth and esophagus showed increasing trends (P<0.05) in some regions and declining trends (P<0.05) in some other.
CONCLUSION: Significant and higher rates of positive trends in lifetime cancer risks for breast cancer among females and for NHL among both sexes were observed.

Entities:  

Mesh:

Year:  2008        PMID: 18319530

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  8 in total

1.  Gastric cancer-a clinicopathological study in a tertiary care centre of North-eastern India.

Authors:  Arun Kumar Barad; Sanjeet Kumar Mandal; Hiriyur S Harsha; Birkumar M Sharma; Th Sudhirchandra Singh
Journal:  J Gastrointest Oncol       Date:  2014-04

2.  Gastric cancer in India: epidemiology and standard of treatment.

Authors:  Chandramohan Servarayan Murugesan; Kanagavel Manickavasagam; Apsara Chandramohan; Abishai Jebaraj; Abdul Rehman Abdul Jameel; Mayank Shikar Jain; Jayanthi Venkataraman
Journal:  Updates Surg       Date:  2018-04-02

3.  Implication of DNA repair genes in prostate tumourigenesis in Indian males.

Authors:  Anju Bansal; Abha Soni; Punita Rao; L C Singh; Ashwani Kumar Mishra; N K Mohanty; Sunita Saxena
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

4.  Gastric cancer in India.

Authors:  Atul Sharma; Venkatraman Radhakrishnan
Journal:  Indian J Med Paediatr Oncol       Date:  2011-01

5.  Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study.

Authors:  Pawni Prabhat; Reshu Tewari; S M Natu; D Dalela; A Goel; P Tandon; M M Goel; K Singh
Journal:  Indian J Urol       Date:  2010-10

6.  A retrospective study of clinico-pathological spectrum of carcinoma breast in a West Delhi, India.

Authors:  Jitendra Singh Nigam; Poonam Yadav; Neelam Sood
Journal:  South Asian J Cancer       Date:  2014-07

7.  Trend and pattern of various types of cancer with special reference to gall bladder cancer in north bengal medical college, west bengal, India: a 3 years record based study.

Authors:  Nilanjana Ghosh; Rajat Bandopadhyay; Louis Tirkey; Dilip Kumar Das
Journal:  Int J Prev Med       Date:  2015-03-24

8.  Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians.

Authors:  Sanjoy Kumar Sureka; Ruchir Maheshwari; Shalini Agnihotri; Nilay Mitash; Shamim Ahmad; Anil Mandhani
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.